The content on this site is intended for healthcare professionals only
ESMO 2020: New developments in the treatment of lung cancer
SABCS 2020: Conference roundup
PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel
Researchers trace the origin of blood cancer to early childhood, decades before diagnosis
Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients
PRIME II update: Omitting radiation therapy after breast-conserving surgery for older breast cancer patients
ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine
Latest data for managing ALK NSCLC patients
FORTE: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma patients
